Solid Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue	0	8.09	13.62	0	0	0	0	0	0
Revenue Growth (YoY)	-	-40.57%	-	-	-	-	-	-	-
Gross Profit	0	8.09	13.62	0	0	0	0	0	0
Selling, General & Admin	27.75	28.95	27.14	21.58	24.58	17.72	14.95	5.46	2.37
Research & Development	76.56	78.42	58.74	64.88	94.74	57.97	39.91	20.12	4.19
Other Operating Expenses	-0.06	7.18	0	1.94	0	0	0	0	0
Operating Expenses	104.25	114.55	85.87	88.41	119.32	75.69	54.86	25.58	6.56
Operating Income	-104.25	-106.45	-72.25	-88.41	-119.32	-75.69	-54.86	-25.58	-6.56
Other Expense / Income	-8.24	-20.47	-0.07	-0.12	-2.1	-0.89	-2.74	-4.04	-0.19
Pretax Income	-96.02	-85.98	-72.19	-88.29	-117.22	-74.8	-52.12	-21.54	-6.38
Net Income	-96.02	-85.98	-72.19	-88.29	-117.22	-74.8	-52.12	-21.54	-6.38
Preferred Dividends	0	0	0	0	0	0	-14.73	-4.31	0.07
Net Income Common	-96.02	-85.98	-72.19	-88.29	-117.22	-74.8	-39.32	-17.23	-6.45
Shares Outstanding (Basic)	20	9	7	3	3	2	1	0	0
Shares Outstanding (Diluted)	20	9	7	3	3	2	1	0	0
Shares Change	133.60%	19.58%	105.58%	28.91%	21.12%	143.69%	703.43%	100.68%	-
EPS (Basic)	-4.83	-10.10	-10.14	-25.50	-43.65	-33.75	-43.20	-152.10	-114.15
EPS (Diluted)	-4.83	-10.10	-10.14	-25.50	-43.65	-33.75	-43.20	-152.10	-114.15
Free Cash Flow	-95.7	-100.39	-79.05	-57.5	-97.1	-77.97	-45.5	-20.51	-4.2
Free Cash Flow Per Share	-4.81	-11.79	-11.11	-16.61	-36.15	-35.16	-50.00	-181.10	-74.49
Gross Margin	-	100.00%	100.00%	-	-	-	-	-	-
Operating Margin	-	-1315.20%	-530.50%	-	-	-	-	-	-
Profit Margin	-	-1062.28%	-530.01%	-	-	-	-	-	-
Free Cash Flow Margin	-	-1240.33%	-580.36%	-	-	-	-	-	-
EBITDA	-93.43	-83.57	-69.22	-84.37	-114.4	-73.23	-51.67	-21.48	-6.38
EBITDA Margin	-	-1032.53%	-508.25%	-	-	-	-	-	-
Depreciation & Amortization	2.58	2.41	2.96	3.92	2.82	1.57	0.45	0.06	0
EBIT	-96.02	-85.98	-72.19	-88.29	-117.22	-74.8	-52.12	-21.54	-6.38
EBIT Margin	-	-1062.28%	-530.01%	-	-	-	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).